BCL-6 Expression in Human T-cell Neoplasms
| Diagnosis* . | No. of Positive/Tested Cases† . |
|---|---|
| Precursor T-cell neoplasm | |
| Precursor T-lymphoblastic lymphoma | 0/8 |
| Peripheral T-cell neoplasms | |
| T-cell chronic lymphocytic leukemia | 0/1 |
| Mycosis fungoides | 0/7 |
| Peripheral T-cell lymphomas | |
| Unspecified | 0/11 |
| AILD-like | 0/4 |
| Angiocentric | 0/1 |
| Anaplastic large-cell CD30+ lymphomas | |
| T cell | 8/19 |
| null cellρ | 4/8 |
| Diagnosis* . | No. of Positive/Tested Cases† . |
|---|---|
| Precursor T-cell neoplasm | |
| Precursor T-lymphoblastic lymphoma | 0/8 |
| Peripheral T-cell neoplasms | |
| T-cell chronic lymphocytic leukemia | 0/1 |
| Mycosis fungoides | 0/7 |
| Peripheral T-cell lymphomas | |
| Unspecified | 0/11 |
| AILD-like | 0/4 |
| Angiocentric | 0/1 |
| Anaplastic large-cell CD30+ lymphomas | |
| T cell | 8/19 |
| null cellρ | 4/8 |
Abbreviation: AILD, angioimmunoblastic T-cell lymphoma.
According to the revised European-American lymphoma classification.14
The percentage of positive neoplastic cells ranged from 10% to 60%.
ρ Null cell group included two cases classified as anaplastic large-cell lymphoma Hodgkin's-like. They were BCL-6 negative.